Precision that accelerates trials
Diagnostic sampling solutions for decentralised and hybrid clinical trials.
Clinical advantages
2-3x
Faster recruitment across decentralised and hybrid trials
40%
Reduction in drop-outs
50%
Lower sample management costs
Our clinical trial kits make a difference
RDi Health delivers diagnostic sampling solutions purpose-built for decentralised and hybrid clinical trials, with integrated kit design, global logistics and fulfilment.
Download our brochure to see how RDi supports sponsors, CROs and trial sites with self-sampling kits, compliant global fulfilment and real-time digital oversight.
Precision data starts with clinical sample collection
Pharma, biotech companies and CROs depend on high‑quality, end‑to‑end diagnostic sampling to support reliable, repeatable trial outcomes. Clear, traceable biomarker data is critical to protocol compliance, data integrity and regulatory confidence.
Clinical trials represent the most expensive and operationally complex phase of new drug development. Improving how samples are collected, tracked and managed delivers measurable gains in data quality and confidence across the trial lifecycle.
Our complete diagnostic solution
A better pathway for your trial
Easy. Compliant. Traceable. Visible.
Choose off-the-shelf, or protocol-specific kit configuration
Patient receives kit at home or in-clinic
Sample collected using standardised instructions
Laboratory receives and processes results
Patient confirmation recorded
Aggregated insights returned to sponsor and trial teams
Reduced site burden and operational complexity
By standardising sampling pathways and removing manual intervention, more efficient trial delivery becomes possible. Well‑designed diagnostic kits, clear workflows and connected systems reduce pressure on sites while supporting consistent execution across study locations.
From protocol‑aligned kit design and global fulfilment to digital onboarding, live tracking and real‑time operational insight, our connected infrastructure supports efficient trial delivery at scale, helping teams reduce friction, maintain oversight and keep trials moving.
Digital diagnosticsenhanced with +CURA
The digital backbone for modern clinical trials.
+CURA is RDi’s cloud-based LIMS and participant-facing digital platform, designed to centralise diagnostic activity across decentralised and hybrid trials.
It provides sponsors, CROs and laboratories with real-time visibility, a fully auditable chain of custody and the operational insight needed to support governance, monitoring and data-driven decision making.
Frequently asked questions
What types of sample collection kits do you support?
RDi supports a broad range of protocol-aligned diagnostic sampling kits suitable for decentralised and hybrid clinical trials.
With over 150 registered kits, plus bespoke configurations, we support:
- Blood and capillary sampling
- Molecular diagnostics and biomarkers
- Genetics testing
- Infectious disease sampling
- Women’s and men’s health (including HPV)
- Long-term condition monitoring
Kits can be configured to meet protocol requirements, study phases and participant populations.
Can RDi support decentralised and hybrid trial designs?
Yes. RDi’s diagnostic pathways are designed specifically to support decentralised and hybrid trials without compromising compliance or data integrity.
Self-sampling enables broader recruitment, reduces site burden and supports consistent participation, while our digital tracking ensures visibility and control across the trial lifecycle.
How do you handle country-specific regulatory requirements for sample shipment and handling?
RDi manages regulatory alignment across international trial logistics.
All kits, packaging and logistics workflows are designed to meet country-specific requirements for the shipment and return of biological samples, including UN3373 Category B compliance.
This reduces regulatory risk while supporting consistent global trial delivery.
How is chain of custody maintained throughout the trial?
Every kit and sample is uniquely identified and digitally tracked from dispatch through return and laboratory receipt.
+CURA provides a fully auditable chain of custody, enabling sponsors and CROs to maintain oversight, support monitoring requirements and demonstrate compliance during audits and inspections.
How does +CURA support trial oversight and reporting?
+CURA provides real-time operational insight across trial diagnostics, including:
- Live kit and sample tracking
- Visibility of volumes and turnaround times
- Insight into adherence and completion
- Audit-ready records for monitoring and reporting
This level of visibility reduces operational risk and supports proactive trial management.
What support is provided to trial participants?
RDi designs participant support to maximise adherence and data completeness.
Each kit includes clear, standardised instructions to minimise collection errors, supported by additional materials where required.
Participant journeys can include:
- Clear onboarding and instructions
- Tracking and confirmation of completion
- Reminders to support compliance
- Multilingual content to support diverse populations
A simple, consistent experience helps improve retention and protocol adherence.
